Diabetic Complications Consortium (DiaComp)


At a Glance
  • Status: Active Consortium
  • Year Launched: 2011
  • Initiating Organization: Department of Health and Human Services
  • Initiator Type: Government
  • Disease focus:
    Diabetes
  • Location: North America

Abstract

The Diabetic Complications Consortium (DiaComp) is focused on collaboration of investigators to combat diabetes. Within DiaComp, grants and awards are available for interested parties to receive funding for research and trial activities.  These opportunities are funded through organizations like the NIH and NIDDK.  Resources and data relating to ongoing and previous research studies are also available on the DiaComp website, creating a transparent environment of sharing and collaboration.

Mission

The goal of the NIDDK-sponsored Diabetic Complications Consortium (DiaComp) is to advance the study of diabetic complications and promote communication and collaboration between investigators involved in complications research. Toward this goal, DiaComp will:

- sponsor annual meetings in complications-relevant scientific areas;

- solicit and fund pilot projects in high impact areas of complications research;

- support a website to serve the diabetic complications community.

Financing

Financial support for DiaComp work is provided by the NIDDK Diabetic Complications Consortium (DiaComp, www.diacomp.org), grant DK076169 

Data Sharing

DiaComp awardees must follow NIH and HHS policies regarding the sharing of data and resources with the scientific community (http://grants.nih.gov/grants/sharing.htm) and agree to submit to the DiaComp web portal all data and resources resulting from the execution of the awarded application. Data and resources may include, but are not limited to:

histology images,
protocols,
experimental data,
microarray data, and
progress report(s).

All data and resources generated with DiaComp support will be made immediately available to “active” DiaComp awardees (see below) and publicly available on the DiaComp website: (1) at the time of first publication, or (2) one year after the award ends. Under certain circumstances, investigators may request an exception to the DiaComp public release policy by contacting NIH Program staff and requesting a waiver. Such requests will be reviewed on a case-by-case basis and waivers will be granted only with sufficient and compelling prior justification.

DiaComp awardees are considered “active” and granted full access to the DiaComp website as members of the DiaComp “Steering Committee” for the duration of their funding period plus 4 years. Outgoing awardees may request an extension from NIH Program staff beyond this “active” period.

Proprietary data and resources will be excluded from sharing consistent with NIH and HHS policies (http://grants.nih.gov/grants/sharing.htm).

Points of Contact

If you have administrative questions about the consortium, such as applying for membership or attending meetings, please contact the coordinator Richard McIndoe (rmcindoe@augusta.edu).

Sponsors & Partners

NIDDK Information Network

NIDDK Central Repository

The GenitoUrinary Development Molecular Anatomy Project (GUDMAP)

International Mouse Phenotyping Consortium

T2D-Genese

T1D Exchange

Diabetes Research Centers

UC Davis Komp Repository Knockout Mouse Project

ReBuilding a Kidney (RBK)

Mouse Metabolic Phenotyping Centers

Human Islet Research Project(HIRN)


Last Updated: 06/19/2017

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.